Beyond directly observed therapy for tuberculosis.
Nolan
C M
CM
D000995:Antitubercular Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D002985:Clinical Protocols; D003362:Cost-Benefit Analysis; D006801:Humans; D009042:Motivation; D009519:New York City; D010349:Patient Compliance; D016896:Treatment Outcome; D016312:Treatment Refusal; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy / Q000191:economics / Q000517:prevention & control; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000191:economics / Q000517:prevention & control; D014481:United States; D014944:World Health Organization
D000995:Antitubercular Agents